Covidence and Rayyan are the two most widely used screening tools for systematic reviews, but they serve different needs and excel in different areas. Covidence is a comprehensive end-to-end review management platform endorsed by Cochrane, while Rayyan is a focused screening tool with superior AI-assisted relevance prediction and a generous free tier. This comparison covers every feature, pricing detail, and use case to help you choose the right tool for your systematic review.
The short answer: if your institution provides Covidence access, use it for its complete workflow coverage. If you need the best free option or are working with a very large number of records, Rayyan's AI screening is hard to beat. Many experienced teams use both, leveraging Rayyan's screening strengths with Covidence's extraction and reporting capabilities.
Head-to-Head Feature Comparison
| Feature | Covidence | Rayyan |
|---|---|---|
| Title-abstract screening | Yes, dual-reviewer with conflict resolution | Yes, dual-reviewer with blind mode |
| Full-text screening | Yes, with PDF upload and annotation | Yes, basic |
| AI-assisted screening | Basic prioritization | Advanced active learning (50-70% time savings) |
| Data extraction | Yes, customizable forms with dual extraction | No |
| Quality assessment | Built-in templates (RoB 2, ROBINS-I, NOS) | No |
| De-duplication | Automatic with manual verification | Automatic with manual verification |
| PRISMA flow diagram | Auto-generated from screening data | Export screening stats |
| RevMan integration | Direct export for Cochrane reviews | No |
| Team collaboration | Full team management with role permissions | Unlimited reviewers, simpler permissions |
| Reference import | RIS, EndNote XML, CSV, PubMed | RIS, BibTeX, CSV, PubMed XML |
| Exclusion reasons | Structured categories at full-text stage | Labels and notes |
| Mobile access | Web browser (responsive) | Dedicated mobile app |
Screening: Where Rayyan Wins
Rayyan's core advantage is its active learning AI model. After you screen approximately 50 to 100 records, Rayyan's algorithm begins predicting the relevance of unscreened records based on patterns in your include/exclude decisions. The model improves with every decision, eventually ranking the most likely relevant studies at the top of your screening queue.
This means you encounter relevant studies early in the process, and as you screen further into increasingly irrelevant records, you can apply stopping rules with confidence that you have found most or all relevant studies. Research has shown that Rayyan's AI can reduce the number of records you need to manually screen by 50 to 70 percent while maintaining sensitivity above 95 percent.
Covidence offers basic machine learning prioritization, but it does not provide the real-time active learning feedback loop that makes Rayyan's screening so efficient. For reviews with large numbers of records (5,000+), this difference translates into weeks of saved screening time.
Rayyan's blind review mode is another screening strength. In blind mode, reviewers cannot see each other's decisions until both have completed screening for a given batch. This ensures truly independent assessment, which is methodologically important for reducing bias in the screening process. Covidence also supports independent screening but does not have a dedicated blind mode interface.
Beyond Screening: Where Covidence Wins
Covidence covers the entire systematic review workflow after screening, which is where Rayyan stops. Once you have identified your included studies, Covidence provides:
Data Extraction
Covidence offers customizable data extraction forms that support dual extraction with reconciliation. Two reviewers independently extract data from each included study, and Covidence highlights discrepancies for resolution. This eliminates the need for separate spreadsheets and reduces extraction errors.
Quality Assessment
Built-in templates for the most common risk of bias tools let you complete quality assessment within the same platform:
- RoB 2 for randomized controlled trials
- ROBINS-I for non-randomized studies
- Newcastle-Ottawa Scale for observational studies
- Custom templates for any other assessment framework
PRISMA Compliance
Covidence auto-generates a PRISMA flow diagram based on your screening and selection decisions, populating the number of records at each stage. This saves significant time compared to manually creating the flow diagram.
Cochrane Integration
For Cochrane review teams, Covidence's direct RevMan export is a major advantage. Extracted data transfers seamlessly into RevMan Web for meta-analysis, forest plot generation, and GRADE assessment.
Pricing Comparison (2026)
| Plan | Covidence | Rayyan |
|---|---|---|
| Free tier | 1 trial review, limited features | 3 active reviews, unlimited reviewers, AI included |
| Individual | $240/year | $20-$35/month premium |
| Institutional | $420/year per seat (volume discounts) | Custom institutional pricing |
| Cochrane access | Often included with Cochrane review group membership | Not applicable |
Check your institutional access first. Many university libraries subscribe to Covidence, giving students and faculty full access at no personal cost. Ask your library or check your institution's research tools portal before purchasing.
Want to skip the software learning curve entirely? Our team uses validated workflows with the best screening and analysis tools to deliver completed systematic reviews in 8 to 12 weeks. Get a free quote, or explore our systematic review services.
Best Use Cases for Each Tool
Choose Covidence When:
- Your institution provides access (most common scenario)
- You are conducting a Cochrane review requiring RevMan integration
- You need data extraction and quality assessment in the same platform
- Your team values an all-in-one workflow over specialized screening features
- Your review has fewer than 3,000 records to screen
Choose Rayyan When:
- You need a free screening tool with no budget for software
- Your review has a large volume of records (5,000+) where AI screening saves weeks
- You want the most advanced AI-assisted screening available
- You are comfortable using a separate tool or spreadsheet for data extraction
- You are working on multiple reviews simultaneously (3 free active reviews)
Use Both When:
- You want Rayyan's AI for initial title-abstract screening (speed) combined with Covidence's structured workflow for full-text screening, extraction, and quality assessment (completeness)
- Your institution has Covidence access but your review has 10,000+ records where Rayyan's AI provides significant screening time savings
Workflow: Using Rayyan and Covidence Together
Many experienced systematic review teams use a combined workflow:
- Import references into Rayyan for title-abstract screening. Take advantage of AI prediction to accelerate screening
- Export included studies from Rayyan as RIS or CSV
- Import into Covidence for full-text screening with PDF management
- Complete data extraction in Covidence using customizable forms
- Run quality assessment in Covidence using built-in RoB 2 or ROBINS-I templates
- Export to RevMan (Cochrane) or to spreadsheet for meta-analysis in R
- Generate PRISMA diagram from Covidence screening statistics
This hybrid workflow gives you the best of both tools: Rayyan's screening efficiency and Covidence's comprehensive review management.
Alternatives Worth Considering
If neither Covidence nor Rayyan fits your needs, consider these alternatives:
- ASReview (free, open source) for AI-prioritized screening with active learning, particularly strong for very large record sets
- DistillerSR (enterprise) for organizations conducting multiple reviews with advanced AI and regulatory compliance features
- EPPI-Reviewer for mixed-methods reviews combining quantitative and qualitative evidence
- Our 32 free research tools including PRISMA flow diagram generator, risk of bias chart, forest plot generator, and effect size calculator for specific analysis phases
For a comprehensive comparison of all available tools, see our best systematic review software guide.
Frequently Asked Questions
The FAQ section below addresses the most common questions about choosing between Covidence and Rayyan.